meglumine antimoniate has been researched along with antimony in 191 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 68 (35.60) | 18.7374 |
| 1990's | 55 (28.80) | 18.2507 |
| 2000's | 43 (22.51) | 29.6817 |
| 2010's | 21 (10.99) | 24.3611 |
| 2020's | 4 (2.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abahussain, A; al-Gindan, Y; alKhawajah, A; Jain, S; Larbi, EB | 1 |
| Bouchouareb, D; Moulin, B; Ollier, J; Olmer, M; Purgus, R | 1 |
| Enriquez, A; García Aguado, C; Gazapo, E; González Lahoz, JM; Laguna, F; Martínez, P; Puente, S | 1 |
| Jennings, FW | 1 |
| Marr, JJ; Martinez, S | 1 |
| Moreira, ES; Petrillo-Peixoto, ML | 1 |
| Almeida, RP; Badaró, F; Badaró, R; Barral, A; Barral-Netto, M; Carvalho, EM; Falcoff, E; Falcoff, R; Pedral-Sampaio, D; Santos, SB | 1 |
| Chapman, WL; Hanson, WL; Lovelace, JK; Waits, VB | 1 |
| Kürkçüoğlu, N; Tandoğdu, R | 1 |
| De Rivera, MV; Franke, ED; Kruger, JH; Lucas, CM; Tovar, AA; Wignall, FS | 1 |
| Dorea, JG; Holzbecher, J; Merchan-Hamann, E; Ryan, DE | 2 |
| Arana, BA; Arana, FE; Castillo, AL; de Mérida, AM; Navin, TR; Pozuelos, JL | 1 |
| Vion, B | 1 |
| Jackson, JE; Tally, JD; Tang, DB | 1 |
| Coutellier, P; Delgrange, B | 1 |
| Chulay, JD; Fleckenstein, L; Smith, DH | 1 |
| Marsden, PD; Sampaio, JH; Sampaio, RN | 1 |
| Santrich, C; Saravia, NG; Valderrama, L; Weigle, KA | 1 |
| Bonventre, PF; Nickol, AD | 2 |
| Dupic, Y; Goutner, C; Massip, P; Navarrot, P | 1 |
| Carvalho, EM; Costa, JL; Llanos-Cuentas, EA; Marsden, PD; Sampaio, RN; Veiga, JP | 1 |
| Anciaux, ML; Bourée, P; Taugourdeau, P | 1 |
| Tsetentis, Y | 1 |
| Chong, H | 1 |
| De Caluwé, JP; Delcourt, A; Heimann, R; Lievens, P; Taelman, H; Trolin, C | 1 |
| Hiçsönmez, G; Jama, H; Ozsoylu, S | 1 |
| Alvar, J; González-Lahoz, JM; Polo, RM; Verdejo, J | 1 |
| Alfred, C; Brandicourt, O; Gentilini, M; Mazier, D; Monjour, L; Nzuzi, KK; Ploton, I; Tselentis, Y; Vouldoukis, I | 1 |
| Belazzoug, S; Neal, RA | 1 |
| Costa, JM; Dorea, JG; Holzbecher, J; Marsden, PD; Ryan, DE | 1 |
| Ayats, R; Cadafalch, J; Orta, C; Portus, M | 1 |
| Gutiérrez Rodero, F | 1 |
| Barrios, LA; Costa, JM; Cuba, CC; Marsden, PD; Netto, EM; Vexenat, CO | 1 |
| Davis, JS; De Alencar, JE; Evans, T; Naidu, TG; Pearson, RD; Wheeler, DA | 1 |
| Barral, A; Barreto, AC; Carvalho, EM; Costa, JM; Cuba, CC; Llanos-Cuentas, EA; Magalhães, AV; Marsden, PD; Netto, EM; Rosa, AC | 1 |
| Ben Rachid, MS; Ben Said, M | 1 |
| Adinolfi, LE; Bonventre, PF | 1 |
| Chapman, WL; Hanson, WL; Madindou, TJ | 1 |
| Adinolfi, LE; Bonventre, PF; Eppstein, DA; Vander Pas, M | 1 |
| Gutiérrez Rodero, F; Moya Jeromini, I; Ortiz de la Tabla Ducasse, V; Pozuelo González, A | 1 |
| Ben Salah, N; Katlama, C; Pichard, E; Régnier, B; Vachon, F | 1 |
| Andreoli, A; Bonora, G; Cambiè, M; Gargantini, G; Giaracuni, G; Manzoni, D; Perletti, L | 1 |
| Marsden, PD; Sampaio, RN; Veiga, JP; Wolff, ER | 1 |
| Steck, EA | 1 |
| Fisher, BK; Schewach-Millet, M; Semah, D | 1 |
| Matthews, PJ; Neal, RA | 1 |
| Heimgartner, E | 1 |
| Hidalgo, H; Solano, E; Zeledón, R | 1 |
| García de Miguel, MJ; García Hortelano, J; López-Herce Cid, J; Ramirez Balza, O; Vidal López, ML | 1 |
| Caravagno, C; Maturana, G; Miranda, C; Moyano, C; Osorio, G; Retamales, I; Ubilla, M | 1 |
| Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD; Swartz, GM; Waits, VB | 1 |
| Ceyhan, M; Diker, S; Dilmen, U; Kinik, E; Yurdakök, M | 1 |
| Barreto, AC; Cuba, CC; Llanos Cuentas, EA; Marsden, PD | 1 |
| Armas, JA; Moreno, G; Rezzano, S; Scorza, JV | 1 |
| Berman, JD; Hanson, WL; Keenan, CM; Lamb, SR; Waits, VB | 1 |
| Alving, CR; Hanson, WL; Munnell, JF; Weldon, JS | 1 |
| Chapman, WL; Hanson, WL; Hendricks, LD | 1 |
| Duvivier, A; Lefèbvre, P; Nemery, A | 1 |
| Kokkini, G; Liosis, G; Papaefstathiou, J; Vrionis, G | 1 |
| Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD | 1 |
| Chapman, WL; Davidson, DE; Hanson, WL; Hendricks, LD; Hockmeyer, WT; Waits, VB | 1 |
| Bódalo Herrero, A; Cambronero Galache, M; Casado Flores, J; Casquero Junquera, J; Courel Grijalba, A; Martínez Cortés, F | 1 |
| Barreto, AC; Cuba, CC; Guerra, M; Magalhâes, A; Marsden, PD; Rocha, RA; Sampaio, RN | 1 |
| Hanson, WL | 1 |
| Avila, JL; Biondo, F; Convit, J; Monzón, H | 1 |
| Almagro, M; Cabrera Torres, A; De Pablos Gallego, JM; De Puerta, S; Esquivias, JJ; Gómez Morales, M; López Garrido, P | 1 |
| Aram, GN; Arya, LS; Fazal, MI; Goel, RG; Qureshi, MA; Singh, M | 1 |
| Carcassonne, Y; Imbert, C; Sainty, D; Sebahoun, G | 1 |
| Moreira, ES; Petrillo-Peixoto, Mde L; Soares, RM | 1 |
| Bryceson, A; Desjeux, P; Gradoni, L | 1 |
| Barbosa, AC; Dorea, JG; Franco, MA; Rath, S | 1 |
| Alcácer, F; Aznar, J; Colomina, J; Ferriols, F; Magraner, J; Orovitg, F; Rodilla, F | 1 |
| Badaró, F; Badaró, R; Carvalho, JS; Ho, JL; Johnson, WD; Jones, TC; Nascimento, C; Reed, SG; Russo, D | 1 |
| Closa, JM; Font, A; Gines, C; Mascort, J | 1 |
| Albertini, M; Gari-Toussaint, M; Le Fichoux, Y; Léger, I; Manassero, J; Mariani, R; Marty, P; Tommasi, C | 1 |
| Belloli, C; Carli, S; Ceci, L; De Natale, G; Madonna, M; Marcotrigiano, GO; Ormas, P; Tassi, P | 1 |
| Añez, N; Burguera, JL; Burguera, M; Lugo de Yarbuh, A; Petit de Peña, Y | 1 |
| Desmyttere, S; Hachimi-Idrissi, S; Otten, J | 1 |
| Alcindor, LG; Ayrault-Jarrier, M; Bekaert, ED; Dubois, DY; Kallel, R; Mebazza, A | 1 |
| Barbieri, CL; Cantos, G; Gorin, PA; Iacomini, M; Travassos, LR | 1 |
| de Lalla, F; Franzetti, M; Gradoni, L; Pellizzer, G; Stecca, C; Vespignani, M | 1 |
| Ozsoylu, S | 1 |
| Cortes, E; de Otero, J; Gasser, I; Ocaña, I; Pahissa, A; Ribera, E | 1 |
| Alcázar, R; de la Torre, M; Peces, R | 1 |
| Alberola, J; Arboix, M; Esteban, M; Valladares, JE | 1 |
| Boix, V; Massa, B; Pérez-Mateo, M; Portilla, J; Torrús, D | 1 |
| Derouin, F; Farinotti, R; Gangneux, JP; Garin, YJ; Sulahian, A | 1 |
| Furtado, T; Nogueira-Castañon, MC; Pereira, CA | 1 |
| Barroeta, S; Bonfante-Garrido, R; de Alejos, MA; Grimaldi Júnior, G; Meléndez, E; Momen, H; Torrealba, J; Valdivia, O | 1 |
| Abdo, MC; Anacleto, C; Fernandes, AP; Ferreira-Pinto, KC; Miranda-Vilela, AL; Moreira, ES; Petrillo-Peixoto, ML | 1 |
| Bertho, AL; Coutinho, SG; Da-Cruz, AM; De Luca, PM; McMahon-Pratt, D; Mendonça, SC; Oliveira, MP; Soong, L | 1 |
| Bai, M; Kastanioudakis, I; Kostoula, A; Skevas, A | 1 |
| Agudelo, S; Berman, J; Grogl, M; Hendrickx, E; Modabber, F; Puerta, J; Velez, I | 1 |
| Deniau, M; Dumon, H; Faraut-Gambarelli, F; Faugère, B; Giusiano, B; Marty, P; Michel, G; Piarroux, R | 1 |
| Astier, A; Bories, C; Deniau, M; Durand, R; Fusai, T; Houin, R; Paul, M; Rivollet, D | 1 |
| Alcázar, R; Benezet, J; De la Torre, M; Ortega-Carnicer, J | 1 |
| Slappendel, RJ; Teske, E | 1 |
| Gonçalves-Costa, SC; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Schubach, A | 1 |
| Aktepe, N; Avci, S; Erel, O; Gurel, MS; Kocyigit, A; Seyrek, A; Vural, H | 1 |
| Amusategui, I; Sainz, A; Tesouro, MA | 2 |
| Berenguer, J; Cano, J; Fernández Alvarez, JM; Gimeno, M; Gonzalo Lafuente, JC; Vázquez-Piñeiro, T | 1 |
| Dumon, H; Garnier, JM; Minodier, P; Perrimond, H; Piarroux, R; Unal, D | 1 |
| Barbosa Santos, EG; Barroso, JA; Brito, CM; Conceição, NF; Marzochi, MC; Pacheco, RS | 1 |
| Anacleto, C; Moreira, ES; Petrillo-Peixoto, ML | 1 |
| Ahmad, S; Rahim, F; Rehman, F; Zada, B | 1 |
| Bitnun, A; Ephros, M; Shaked, P; Waldman, E; Zilberstein, D | 1 |
| Chantraine, JM; Dresse, MF; Gillet, P; Hoyoux, C; Marguglio, A; Thiry, A | 1 |
| Belloli, C; Bertini, S; Carli, S; Crescenzo, G; Mengozzi, G; Ormas, P; Zaghini, A | 1 |
| Atienza Fernández, F; Castelló Viguer, MT; Cuesta Estellés, G; Echánove Errazti, I; Esteban Esteban, E; Ridocci Soriano, F | 1 |
| Corzo, JE; de la Rosa, R; Delgado, J; González-Moreno, MP; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
| González Lahoz, J; Laguna, F; Valencia, ME | 1 |
| Arboix, M; Carrió, J; de Colmenares, M; Gállego, M; Portús, M; Riera, C | 1 |
| Hantson, P; Haufroid, V; Lambert, M; Luyasu, S | 1 |
| Márquez, M; Rivero, A; Santos, J | 1 |
| Costa, MA; Demicheli, C; Ferreira, CS; Frézard, F | 1 |
| Afonso, LC; Costa , CA; Genaro, O; Gollob, KJ; Mayrink, W; Oliveira, MA; Pinto, JA; Toledo, VP | 1 |
| Anacleto, C; Andrade, AF; Ferreira, AV; Gazola, KC; Michalick, MS; Moreira, ES | 1 |
| Arana, B; Diaz, A; Rizzo, N | 1 |
| Miekeley, N; Mortari, SR; Schubach, AO | 1 |
| Carrió, J; Portús, M | 1 |
| Bulut, V; Gur, S; Gurel, MS; Kocyigit, A; Ulukanligil, M | 1 |
| Bogenrieder, T; Landthaler, M; Lehn, N; Stolz, W | 1 |
| NOGUER MORE, S | 1 |
| BOIX BARRIOS, J | 1 |
| BAPTISTA, L; BELLIBONI, N; CASTRO, RM | 1 |
| BERNARD, R; GIRAUD, P; VINCENT, P | 1 |
| FLOCH, H | 1 |
| CORNEJO, A | 1 |
| MATOS, J; VELASCO, JA | 1 |
| CARVALHO, O | 1 |
| PI FERRER, A; SALA GINABREDA, JM; WOESSNER CASAS, S | 1 |
| CAMBI, P | 1 |
| Allahverdiyev, AM; Culha, G; Durdu, M; Memisoglu, HR; Uzun, S | 1 |
| Saravia, NG; Walker, J | 1 |
| Delis, D; Kafetzis, DA; Liapi, G; Mavrikou, M; Stabouli, S; Velissariou, IM | 1 |
| Gómez, A; Henao, HH; Osorio, Y; Saravia, NG; Travi, B | 1 |
| Bouassida, S; Boudaya, S; Maalej, N; Masmoudi, A; Mseddi, M; Souissi, A; Turki, H; Zahaf, A | 1 |
| De-Carvalho, RR; Miekeley, N; Miranda, ES; Paumgartten, FJ | 1 |
| Bouassida, S; Kitar, A; Masmoudi, A; Rebai, M; Turki, H; Zahaf, A | 1 |
| Atabek, ME; Pirgon, O; Unal, E | 1 |
| de Oliveira, FB; Demicheli, C; Dzamitika, SA; Falcão, CA; Frézard, F; Garnier-Suillerot, A; Marbeuf, C; Rossi-Bergmann, B | 1 |
| Demicheli, C; Frézard, F; Melo, MN; Michalick, MS; Ribeiro, RR; Rocha, OG; Schettini, DA | 1 |
| Ouellette, M; Rojas, R; Saravia, NG; Valderrama, L; Valderrama, M; Varona, MX | 1 |
| Buffet, PA; Darie, H; Freitag, S; Gounod, N; Le Guern, AS; Therby, A; Van Der Vliet, D | 1 |
| de Castro Pimenta, AM; Demicheli, C; dos Santos Ferreira, C; Frézard, F | 1 |
| Dowlati, Y; Eskandari, SE; Firooz, A; Ghoorchi, MH; Gorouhi, F; Hooshmand, B; Khamesipour, A; Khatami, A; Nassiri-Kashani, M; Rashighi-Firoozabadi, M | 1 |
| Cruz, A; Herwaldt, BL; Palacios, R; Rainey, PM; Saravia, NG; Stagni, G; Trujillo, R | 1 |
| Soto, J; Soto, P | 1 |
| Mumtaz, N; Rahman, SB; ul Bari, A | 1 |
| Adaui, V; Arevalo, J; Chappuis, F; De Doncker, S; Dujardin, JC; Lazo, M; Llanos-Cuentas, A; Loayza-Muro, R; Maurer, A; Miranda-Verástegui, C; Ramirez, L; Tulliano, G; Zimic, M | 1 |
| Blanc, P; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Uters, M | 1 |
| Azeredo-Coutinho, RB; Callahan, H; Max, G; Mendonça, SC; Portal, AC | 1 |
| Bahia, AP; da Silva, JB; de Melo, AL; Demicheli, C; Frézard, F; Le Moyec, L; Martins, PS; Pimenta, AM; Salerno, M | 1 |
| Akrout, F; Ayadi, N; Bouassida, S; Boudaya, S; Khabir, A; Masmoudi, A; Meziou, TJ; Sallemi, T; Turki, H; Zahaf, A | 1 |
| Ammari, L; Belhadj, S; Ben Chaabene, T; Chaker, E; Kanoun, F; Kilani, B; Tiouiri, H; Toumi, A | 1 |
| de Moura, FJ; de Souza Furtado, R; Leal, PP; Muniz-Junqueira, MI; Veiga, JP | 1 |
| Dahdah, MJ; Ghosn, S; Kibbi, AG | 1 |
| Carrió, J; García, E; Miñarro, M; Pérez, P; Portus, M; Pujals, G; Suñé-Negre, JM; Tico, JR | 1 |
| Cabral, LM; Castro, HC; Dias, LR; Dornelas, CB; Juliano, VN; Rodrigues, CR; Santos, TC; Villardi, M | 1 |
| Sadeghi, M; Sadeghian, G; Ziaei, H | 1 |
| Kubota, LT; Santos, VS; Santos, Wde J; Tarley, CR | 1 |
| Brustoloni, YM; Cônsolo, CE; Melnikov, P; Zanoni, LZ | 1 |
| Friedrich, K; Grimaldi, G; Marchevsky, RS; Miekeley, N; Paumgartten, FJ; Porrozzi, R; Teva, A; Vieira, F | 1 |
| Alves, EV; Arruda, VO; de Azevedo, AP; Lima, MI; Monteiro, SG; Pereira, SR | 1 |
| Caldas, ED; Neves, DB; Sampaio, RN | 1 |
| Demicheli, C; Ferreira, WA; Frézard, F; Le Moyec, L; Martins, PS; Neto, RL; Ribeiro, RR; Rocha, OG | 1 |
| Adaui, V; Arévalo, J; Cupolillo, E; Dujardin, JC; Ribeiro-Alves, M; Romero, GA; Torres, DC | 1 |
| Abbas, MM; Masood, S; Mumtaz, MJ; Rashid, BN; Tabassum, S; Ullah Rao, MS | 1 |
| Craft, N; Da-Cruz, AM; de Oliveira, MP; de Oliveira-Neto, MP; Maretti-Mira, AC; Pirmez, C | 1 |
| Friedrich, K; Grimaldi, G; Marchevsky, RS; Miekeley, N; Paumgartten, FJ; Porrozzi, R; Vieira, FA | 1 |
| Korkmaz, M; Özbel, Y; Şakru, N; Töz, SÖ | 1 |
| Baker, NC; Blanco, V; Craft, N; Garcerant, D; Martinez, J; Rubiano, L | 1 |
| Donard, OF; Gleyzes, C; Grosso, O; Plau, B; Séby, F | 1 |
| Frézard, F; Salaün, P | 1 |
| Andrade, HF; Borborema, SE; Nascimento, Nd; Osso, JA | 1 |
| Abedkhojasteh, H; Hadighi, R; Hajjaran, H; Heidari, M; Kazemi-Rad, E; Khadem-Erfan, MB; Khamesipour, A; Mohebali, M; Raoofian, R; Rezaie, S; Saffari, M | 1 |
| Andrade, AP; Demicheli, C; Fernandes, FR; Ferreira, WA; Frézard, F; Islam, A | 1 |
| Diaz-Toro, Y; Fernández, OL; Gomez, MA; Muvdi, S; Ovalle, C; Rodríguez, I; Saravia, NG; Valderrama, L | 1 |
| Coelho, DR; Miranda, ES; Paumgartten, FJ; Saint'Pierre, TD | 1 |
| Coelho, DR; De-Carvalho, RR; Paumgartten, FJ; Rocha, RC; Saint'Pierre, TD | 1 |
| Bhattacharjee, H; Charret, KS; Mandal, G; Mandal, S; Mukhopadhyay, R; Papadopoulou, B; Sharma, M | 1 |
| Andrade, MS; Corrêa-Júnior, JD; Demicheli, C; Fernandes, FR; Ferreira, LA; Frézard, F; Lanza, JS; Magalhães-Paniago, R; Melo, MN; Vilela, JM | 1 |
| Castanys, S; Corpas-López, V; Gamarro, F; García-Hernandez, R; Gómez Pérez, V; Martín-Sanchez, J; Tomás, AM | 1 |
| Brito, NC; Cota, GF; Rabello, A | 1 |
| Bomfim, LGS; de Almeida, RP; de Jesus, AR; de Moura, TR; Dos Santos, PL; Lipscomb, MW; Magalhães, LS; Santos, CNO; Tanajura, DM | 1 |
| Alkan Yılmaz, Ö; Evren, V; Harman, M; Özbilgin, A; Turgay, N; Zorbozan, O | 1 |
| Alves, CR; Conceição-Silva, F; Dias-Lopes, G; Miranda, LFC; Souza-Silva, F; Zabala-Peñafiel, A | 1 |
| Gonzalez, AA; Ogra, Y; Quiroz, W; Roldán, N; Suzuki, N; Verdugo, M | 1 |
11 review(s) available for meglumine antimoniate and antimony
| Article | Year |
|---|---|
Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient.
Topics: Adult; Allopurinol; Animals; Antimony; Antiprotozoal Agents; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Methylprednisolone; Muromonab-CD3; Organometallic Compounds | 1992 |
Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis.
Topics: Allopurinol; Aminoquinolines; Antimony; Antimony Sodium Gluconate; Cryosurgery; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Levamisole; Liposomes; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Phenothiazines; Rifampin | 1986 |
[Visceral kala-azar of Spanish origin. Apropos of a case].
Topics: Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1988 |
The chemotherapy of protozoal infections: whither?
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Models, Animal; Glycolipids; Humans; Leishmaniasis; Leishmaniasis, Visceral; Liposomes; Lysosomes; Malaria; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primaquine; Protozoan Infections; Trypanosomiasis | 1981 |
[Kala-azar. Presentation of 7 cases and review of the literature].
Topics: Antimony; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Organometallic Compounds; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Chemotherapy and the immune response in protozoal infections.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antibody Formation; Antimalarials; Antimony; Antiprotozoal Agents; Humans; Immune Tolerance; Immunity, Cellular; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Protozoan Infections | 1981 |
[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Substance Abuse, Intravenous | 2000 |
Chemotherapy of cutaneous leishmaniasis: a review.
Topics: Antifungal Agents; Antimony; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Ointments; Organometallic Compounds; Phosphorylcholine | 2001 |
[Current situation and future of antileishmanial therapy in Colombia].
Topics: Antimony; Antiprotozoal Agents; Colombia; Forecasting; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2006 |
[Treatment of visceral leishmaniasis in children].
Topics: Amphotericin B; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2007 |
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cryotherapy; Databases, Factual; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2017 |
12 trial(s) available for meglumine antimoniate and antimony
| Article | Year |
|---|---|
Allopurinol in the treatment of American cutaneous leishmaniasis.
Topics: Adolescent; Adult; Allopurinol; Antimony; Antiprotozoal Agents; Child, Preschool; Developing Countries; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.
Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Follow-Up Studies; Guatemala; Hot Temperature; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Military Personnel; Organometallic Compounds; Radio Waves; Randomized Controlled Trials as Topic; Sorbitol | 1990 |
Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.
Topics: Adolescent; Algeria; Antimony; Antiprotozoal Agents; Child; Clinical Trials as Topic; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
Treatment of Mediterranean visceral leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Europe; Humans; Infant; Leishmaniasis, Visceral; Liposomes; Mediterranean Islands; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1995 |
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Health Care Costs; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Neutropenia; Organometallic Compounds; Pilot Projects; Recombinant Proteins; Severity of Illness Index | 1994 |
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
Topics: Adult; Aged; Allopurinol; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Data Interpretation, Statistical; Female; Follow-Up Studies; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Organometallic Compounds; Recurrence; Retrospective Studies; Time Factors | 1996 |
Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial.
Topics: Adult; Allopurinol; Antimetabolites; Antimony; Antiprotozoal Agents; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Failure | 1997 |
The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial.
Topics: Animals; Antimony; Antiprotozoal Agents; Disease-Free Survival; Dog Diseases; Dogs; Female; Injections, Intravenous; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Remission Induction; Treatment Outcome | 1997 |
Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens.
Topics: Adult; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1997 |
Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Cytokines; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2002 |
Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Animals; Antimony; Antiprotozoal Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Single-Blind Method; Treatment Outcome | 2006 |
Miltefosine in cutaneous leishmaniasis.
Topics: Adult; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2007 |
168 other study(ies) available for meglumine antimoniate and antimony
| Article | Year |
|---|---|
Subacute toxicity of pentavalent antimony compounds in rats.
Topics: Alkaline Phosphatase; Animals; Antimony; Antimony Sodium Gluconate; Behavior, Animal; Bilirubin; Blood Cell Count; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Female; Hemoglobins; Kidney; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rats; Weight Gain | 1992 |
[Visceral leishmaniasis: a study of 15 cases].
Topics: Age Factors; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Serologic Tests; Sex Factors; Spain | 1992 |
Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO).
Topics: Animals; Antimony; Antimony Sodium Gluconate; Drug Synergism; Drug Therapy, Combination; Eflornithine; Female; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Succimer; Tartrates; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
In vitro activity of meglumine antimoniate, a pentavalent antimonial drug, on Leishmania promastigotes.
Topics: Animals; Antimony; Antiprotozoal Agents; In Vitro Techniques; Leishmania; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors | 1991 |
Tumor necrosis factor (cachectin) in human visceral leishmaniasis.
Topics: Acute Disease; Antimony; Antiprotozoal Agents; Cells, Cultured; Combined Modality Therapy; Female; Humans; Interferon-gamma; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |
Development of Leishmania (Viannia) panamensis lesions and relationship of numbers of amastigotes to lesion area on antimony-treated and untreated hamsters.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin | 1991 |
Interferon gamma therapy for cutaneous leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Humans; Interferon-gamma; Leishmania tropica; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins | 1990 |
Diffuse cutaneous leishmaniasis acquired in Peru.
Topics: Adult; Antimony; Antiprotozoal Agents; Biopsy; Female; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Peru; Skin | 1990 |
Retention of antimony in skin biopsies of leishmaniasis patients after treatment with N-methylglucamine antimoniate.
Topics: Adolescent; Adult; Aged; Antimony; Biopsy; Child; Double-Blind Method; Drug Administration Schedule; Humans; Injections, Intravenous; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Neutron Activation Analysis; Organometallic Compounds; Random Allocation; Skin; Sorbitol | 1990 |
[Cutaneous leishmaniasis].
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1989 |
An in vitro micromethod for drug sensitivity testing of Leishmania.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Culture Media; Gluconates; Humans; Least-Squares Analysis; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Sorbitol; Time Factors | 1989 |
[Kala-azar. Apropos of a case report in a Belgian woman].
Topics: Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol | 1989 |
Retention of antimony in hair during leishmaniasis treatment.
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Child; Drug Administration Schedule; Hair; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1989 |
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Gluconates; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Pentavalent antimonial treatment in mucosal leishmaniasis.
Topics: Antimony; Drug Administration Schedule; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nifurtimox; Nitrofurans; Organometallic Compounds | 1985 |
Recurrences of tegumentary leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence | 1985 |
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells.
Topics: Animals; Antigens, Protozoan; Antimony; Immune Tolerance; Interleukin-2; Leishmania donovani; Leishmaniasis, Visceral; Lymphocyte Activation; Macrophage Activation; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred Strains; Organometallic Compounds; Spleen; T-Lymphocytes, Regulatory | 1985 |
[Kala-azar in pregnant women].
Topics: Adult; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pregnancy; Pregnancy Complications, Infectious | 1986 |
High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis.
Topics: Adult; Amphotericin B; Antimony; Antimony Sodium Gluconate; Child; Gluconates; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Topics: Adolescent; Adult; Antimony; Antimony Sodium Gluconate; Child; Child, Preschool; Female; Gluconates; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Splenectomy | 1985 |
[Treatment of visceral leishmaniasis].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Pentamidine | 1985 |
Severe leucopenia during treatment of visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmaniasis, Visceral; Leukocyte Count; Leukopenia; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
Topics: Antimony; Antiprotozoal Agents; Humans; Immune Tolerance; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
[Culture systems for production of promastigote and amastigote forms of Leishmania. Application to serological diagnosis and therapeutic trials].
Topics: Animals; Antimony; Antiprotozoal Agents; Cell Line; Culture Media; Fluorescent Antibody Technique; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Serologic Tests; Time Factors | 1986 |
Antimony accumulation in hair during treatment of leishmaniasis.
Topics: Antimony; Brazil; Hair; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Neutron Activation Analysis; Organometallic Compounds; Retrospective Studies; Sorbitol | 1987 |
[Visceral leishmaniasis mimicking histiocytic marrow reticulosis].
Topics: Adult; Antimony; Bone Marrow; Diagnosis, Differential; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Lymphatic Diseases; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phagocytosis | 1986 |
[Agranulocytosis caused by glucantime in the treatment of kala-azar].
Topics: Agranulocytosis; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
Intralesional glucantime in Leishmania braziliensis braziliensis infections.
Topics: Adult; Antimony; Antiprotozoal Agents; Child, Preschool; Female; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
Humoral factors during South American visceral leishmaniasis.
Topics: Adolescent; Adult; Antibodies; Antigen-Antibody Complex; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Complement Fixation Tests; Female; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rheumatoid Factor | 1986 |
Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Brazil; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
[Value of the ELISA IgG and IgM test in the diagnosis and post-therapeutic monitoring of kala-azar].
Topics: Antimony; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunoglobulin G; Immunoglobulin M; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rheumatoid Factor | 1985 |
Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1).
Topics: Adjuvants, Immunologic; Animals; Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis, Visceral; Lymphokines; Macrophage Activation; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Organometallic Compounds; Piperidines; Thioglycolates | 1985 |
Chemotherapy of visceral leishmaniasis (Leishmania donovani) in the squirrel monkey (Saimiri sciureus).
Topics: Animals; Antimony; Antiprotozoal Agents; Female; Leishmania; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Saimiri | 1985 |
Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antimony; Antiprotozoal Agents; Combined Modality Therapy; Cricetinae; Female; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds | 1985 |
[Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar].
Topics: Adult; Agranulocytosis; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
Immunosuppression associated with visceral leishmaniasis of hamsters.
Topics: Animals; Antigens, Protozoan; Antimony; Cricetinae; Immune Tolerance; Leishmania; Leishmaniasis, Visceral; Lymphocyte Activation; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Time Factors | 1985 |
[Toxicity of Glucantime. A case].
Topics: Adult; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
[Description of a case of visceral leishmaniasis. Epidemiologic, diagnostic and therapeutic considerations].
Topics: Antimony; Child, Preschool; Humans; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Gluconates; Humans; Kidney Diseases; Kidney Tubules; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1983 |
Leishmaniasis recidivans treated with sodium stibogluconate.
Topics: Adult; Anti-Bacterial Agents; Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence | 1981 |
In vivo antileishmanial properties of pentavalent antimonial compounds.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Gluconates; Leishmania; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred Strains; Organometallic Compounds | 1982 |
[Cutaneous leishmaniasis in patients returning from the tropics].
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Benzenesulfonates; Female; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sulfamethoxazole; Travel; Tropical Climate | 1984 |
[Successful intralesional treatment of leishmaniasis caused by Leishmania brasiliensis panamensis using glucantime].
Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1984 |
[Visceral leishmaniasis (kala-azar): 1st case observed in Chile].
Topics: Adult; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 1984 |
Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Leishmania; Leishmaniasis, Visceral; Liposomes; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Virulence | 1984 |
[The hyperglycemic effect of N-methylglucamine antimonate (glucantime)].
Topics: Animals; Antimony; Blood Glucose; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Hyperglycemia; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds | 1984 |
Clinical characteristics of human Leishmania braziliensis braziliensis infections.
Topics: Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mucous Membrane; Organometallic Compounds | 1984 |
[Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Sex Factors | 1984 |
Leishmania donovani: oral efficacy and toxicity of formycin B in the infected hamster.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antimony; Bilirubin; Bone Marrow; Cricetinae; Drug Evaluation, Preclinical; Formycins; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds | 1983 |
Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway.
Topics: Animals; Antimony; Cricetinae; Kupffer Cells; Leishmania; Leishmaniasis, Visceral; Liposomes; Lysosomes; Macrophages; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Microscopy, Electron; Organometallic Compounds; Phagocytosis; Spleen | 1983 |
Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus).
Topics: Animals; Antimony; Antiprotozoal Agents; Aotus trivirgatus; Cebidae; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Monkey Diseases; Organometallic Compounds | 1983 |
[A case of visceral leishmaniasis].
Topics: Aged; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1984 |
Cold agglutinin syndrome and hemophagocytosis in systemic leishmaniasis.
Topics: Anemia, Hemolytic, Autoimmune; Antimony; Bone Marrow Cells; Child, Preschool; Histiocytes; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phagocytosis | 1984 |
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog.
Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1984 |
Relative insensitivity of a Kenyan strain of Leishmania donovani to pentavalent antimony therapy in hamsters.
Topics: Animals; Antimony; Cricetinae; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1983 |
[Kala-azar in childhood. 20 year review].
Topics: Adolescent; Age Factors; Aniline Compounds; Antimony; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sex Factors; Spain; Stilbenes | 1983 |
Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.
Topics: Amphotericin B; Antigens; Antimony; Brazil; Female; Fluorescent Antibody Technique; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol | 1980 |
Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy.
Topics: Animals; Antimony; Dose-Response Relationship, Immunologic; Female; Glucans; Immunotherapy; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Mononuclear Phagocyte System; Organometallic Compounds; Sorbitol | 1982 |
[Kala-azar and autoimmune hemolytic anemia. Apropos of a fatally developing case caused by hepatotoxicity from N-methylglucamine antimonate].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antimony; Chemical and Drug Induced Liver Injury; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1982 |
Kala-azar in Afghanistan.
Topics: Afghanistan; Antimony; Antiprotozoal Agents; Child, Preschool; Female; Hepatomegaly; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 1982 |
[Adult Mediterranean visceral leishmaniasis: report of 12 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Antimony; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1980 |
Glucantime susceptibility of Leishmania promastigotes under variable growth conditions.
Topics: Animals; Antimony; Antiprotozoal Agents; Biopterins; Cell Division; Culture Media; Fatty Acids; Folic Acid; Leishmania; Leishmania braziliensis; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Oleic Acid; Oleic Acids; Organometallic Compounds; Species Specificity | 1995 |
Antimony oxidation states in antileishmanial drugs.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Stability; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxidation-Reduction | 1995 |
Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Substance Abuse, Intravenous | 1994 |
Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
Topics: Animals; Antimony; Antiprotozoal Agents; Disseminated Intravascular Coagulation; Dog Diseases; Dogs; Female; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1994 |
[Childhood visceral leishmaniasis in the Alpes-Maritimes from 1985 to 1992].
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; France; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies | 1994 |
Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in the dog.
Topics: Animals; Antimony; Biological Availability; Dogs; Female; Half-Life; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Male; Meglumine; Meglumine Antimoniate; Metabolic Clearance Rate; Organometallic Compounds | 1994 |
Antimony determination in tissues and serum of hamsters infected with Leishmania garnhami and treated with meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Tissue Distribution | 1994 |
[Visceral leishmaniasis: a possible diagnosis in Belgium].
Topics: Antimony; Antiprotozoal Agents; Diagnosis, Differential; Female; Humans; Infant; Leishmaniasis, Visceral; Leukemia; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1993 |
Acute phase proteins and plasma lipoproteins during antimony treatment in infantile visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Apolipoproteins; C-Reactive Protein; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1993 |
Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages.
Topics: Animals; Antimony; Antiprotozoal Agents; Carbohydrate Sequence; Cricetinae; Drug Carriers; Lectins, C-Type; Leishmania; Leishmaniasis; Macrophages; Mannans; Mannose; Mannose Receptor; Mannose-Binding Lectins; Meglumine; Meglumine Antimoniate; Mice; Molecular Sequence Data; Organometallic Compounds; Receptors, Cell Surface; Receptors, Immunologic; Saccharomyces cerevisiae | 1993 |
Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
Topics: Acute Disease; Adult; Antimony; Antiprotozoal Agents; Female; Ghana; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1993 |
Treatment of kala azar.
Topics: Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1996 |
Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis.
Topics: Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Antitubercular Agents; Humans; Kidney Failure, Chronic; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Remission Induction; Renal Dialysis; Tuberculosis, Renal | 1996 |
Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs.
Topics: Animals; Antimony; Antiprotozoal Agents; Biological Availability; Dog Diseases; Dogs; Half-Life; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1996 |
Meglumine antimoniate-induced pancreatitis.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1996 |
Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Carriers; Female; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 1996 |
Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV Antibodies; Humans; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1996 |
Disseminated American cutaneous leishmaniasis.
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Azure Stains; Biopsy; Child; Cricetinae; Culture Media; Cytodiagnosis; Drug Administration Schedule; Drug Resistance; Female; Histiocytes; Humans; Injections, Intradermal; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin Tests; Skin Ulcer; Venezuela | 1996 |
Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.
Topics: Animals; Antimony; Antimony Potassium Tartrate; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenates; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA, Protozoan; Drug Resistance; Drug Resistance, Multiple; Gene Dosage; Genes, Protozoan; Leishmania; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxides; Puromycin; Sequence Homology, Nucleic Acid; Vinblastine | 1996 |
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Topics: Animals; Antigens, Protozoan; Antimony; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytokines; Female; Humans; Interferon-gamma; Interleukin-2; Interleukin-4; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; T-Lymphocytes | 1996 |
Old-world leishmaniasis of the auricle.
Topics: Adult; Antimony; Antiprotozoal Agents; Ear Diseases; Ear, External; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1997 |
In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Polymerase Chain Reaction | 1997 |
Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model.
Topics: Animals; Antimony; Antiprotozoal Agents; Colloids; Disease Models, Animal; Drug Carriers; Female; Leishmania major; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microspheres; Organometallic Compounds; Pentamidine; Polymethacrylic Acids; Random Allocation | 1994 |
Pentavalent antimonial-induced torsade de pointes.
Topics: Aged; Anti-Arrhythmia Agents; Antimony; Antiprotozoal Agents; Electrocardiography; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Torsades de Pointes | 1997 |
Effects of antimonial therapy on serum zinc, copper and iron concentrations in patients with cutaneous Leishmaniasis in Turkey.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Copper; Humans; Iron; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trace Elements; Turkey; Zinc | 1998 |
Effects of antimonial therapy for canine leishmaniasis on antibody titer.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Time Factors | 1998 |
Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Topics: Allopurinol; Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Serum Albumin; Serum Globulins; Time Factors | 1998 |
Visceral leishmaniasis: a lingual presentation in a patient with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antimony; Antiprotozoal Agents; Didanosine; HIV Infections; Humans; Laryngitis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain; Tongue Diseases; Zidovudine | 1998 |
Pediatric visceral leishmaniasis in southern France.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; France; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quaternary Ammonium Compounds; Retrospective Studies; Treatment Failure; Treatment Outcome | 1998 |
N-methylglucamine antimonate (SbV+): intralesional canine tegumentary leishmaniasis therapy.
Topics: Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dogs; Female; Immunity, Cellular; Injections, Intralesional; Isoenzymes; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1998 |
Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility.
Topics: Animals; Antimony; Antiprotozoal Agents; DNA, Protozoan; Humans; Leishmania; Leishmania braziliensis; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Open Reading Frames; Organometallic Compounds; Species Specificity | 1998 |
Visceral leishmaniasis in District Dir, NWFP.
Topics: Abdomen; Anemia; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; Fever; Hepatomegaly; Humans; Hypergammaglobulinemia; Leishmania donovani; Leishmaniasis, Visceral; Leukopenia; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pakistan; Splenomegaly; Thrombocytopenia; Weight Loss | 1998 |
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenites; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
[Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma].
Topics: Amphotericin B; Antifungal Agents; Antimony; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Child; Chronic Disease; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Lung Neoplasms; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteosarcoma; Recurrence; Spinal Neoplasms | 1998 |
Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs.
Topics: Amebicides; Animals; Antimony; Antiprotozoal Agents; Area Under Curve; Chromatography, Liquid; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluorometry; Half-Life; Injections, Subcutaneous; Least-Squares Analysis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Spectrophotometry, Atomic | 1999 |
[Torsades de pointes during treatment of leishmaniasis with meglumine antimoniate].
Topics: Aged; Antimony; Antiprotozoal Agents; Electrocardiography; Female; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Torsades de Pointes | 1999 |
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
Topics: Adult; Amylases; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Creatinine; Female; HIV Infections; HIV-1; Humans; Leishmania infantum; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence; Retrospective Studies; Vomiting | 1999 |
[Nephrotic syndrome and acute pancreatitis related to glucantime administration].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Nephrotic Syndrome; Organometallic Compounds; Pancreatitis | 2000 |
Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Culture Media; Dogs; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds | 2000 |
Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy.
Topics: Antimony; Antiprotozoal Agents; Creatinine; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Oliguria; Organometallic Compounds; Renal Insufficiency; Shock, Septic | 2000 |
Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate.
Topics: Antimony; Glutathione; Hydrogen-Ion Concentration; Kinetics; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxidation-Reduction; Temperature | 2001 |
Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment.
Topics: Adult; Animals; Antigens, Protozoan; Antimony; Antiprotozoal Agents; Cytokines; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-10; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Vaccines | 2001 |
Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines.
Topics: Animals; Antimony; Antiprotozoal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cricetinae; Disease Models, Animal; Drug Resistance; Glycosphingolipids; Lectins; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Time Factors | 2001 |
Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis.
Topics: Adult; Antimony; Antiprotozoal Agents; Chromatography, Ion Exchange; Gas Chromatography-Mass Spectrometry; Hair; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2002 |
In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests | 2002 |
Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
Topics: Adolescent; Antimony; Antiprotozoal Agents; Equipment Design; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2003 |
[Parenteral glucantime therapy of bouton d'orient, with esthetic results superior to intralesional therapy].
Topics: Antimony; Esthetics; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1952 |
[N-methylglucamine antimoniate in the treatment of visceral leishmaniasis; first cases treated in Spain].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain | 1952 |
[Case of sporotrichosis treated with N-methylglucamine antimoniate].
Topics: Antimony; Humans; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sporotrichosis | 1952 |
[Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime].
Topics: Antimony; Hypersensitivity; Immune System Diseases; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1954 |
[The activity of intramuscular glucantime and of intravenous anthiomaline in the treatment of sylvan American leishmaniasis].
Topics: Antimony; Furans; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
[Leishmaniasis mucocutaneous americana; our experience in its treatment with glucantime].
Topics: Antimony; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
[Two cases of kala-azar treated with glucantime].
Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
[Test treatment with N-methylglucamine antimoniate in the diagnosis of kala-azar in children].
Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1958 |
[8 cases of kala-azar cured with glucantime].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1962 |
[N-methylglucamine antimoniate (glucantime) in therapy of infantile visceral leishmaniasis; a further case of autocthonous infantile visceral leishmaniasis on the island of Elba].
Topics: Antimony; Humans; Islands; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Cryosurgery; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Turkey | 2004 |
Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
Topics: Animals; Antimony; Antimony Potassium Tartrate; Antimony Sodium Gluconate; Antiprotozoal Agents; Benzimidazoles; Bisbenzimidazole; Camptothecin; Cell Survival; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Leishmania donovani; Meglumine; Meglumine Antimoniate; Monocytes; Organometallic Compounds; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; U937 Cells | 2004 |
Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Topics: Adolescent; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Female; Greece; Humans; Infant; Infant, Newborn; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2005 |
[Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2004 |
[Glucantime injection: benefit versus toxicity].
Topics: Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Exanthema; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pain; Retrospective Studies | 2005 |
Developmental toxicity of meglumine antimoniate and transplacental transfer of antimony in the rat.
Topics: Abnormalities, Drug-Induced; Animals; Antimony; Antiprotozoal Agents; Bone and Bones; Dose-Response Relationship, Drug; Female; Fetal Blood; Fetal Death; Fetal Development; Fetal Weight; Maternal-Fetal Exchange; Meglumine; Meglumine Antimoniate; No-Observed-Adverse-Effect Level; Organometallic Compounds; Placenta; Pregnancy; Rats; Rats, Wistar | 2006 |
[The cutaneous leishmaniasis of the face in Gafsa area, Tunisia].
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Endemic Diseases; Facial Dermatoses; Female; Humans; Incidence; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Necrosis; Nose Diseases; Organometallic Compounds; Prospective Studies; Skin Ulcer; Tunisia | 2005 |
Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes.
Topics: Adolescent; Antimony; Antiprotozoal Agents; Blood Glucose; Diabetes Mellitus, Type 1; Female; Humans; Knee; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2006 |
Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
Topics: Animals; Antimony; Antiprotozoal Agents; Cations; Cell Line; Drug Resistance, Microbial; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Organometallic Compounds | 2006 |
Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size.
Topics: Animals; Antimony; Bone Marrow; Dogs; Drug Delivery Systems; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Particle Size; Tissue Distribution | 2006 |
Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Child; Drug Resistance; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Parasitic Sensitivity Tests; Treatment Failure; U937 Cells | 2006 |
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy.
Topics: Adult; Animals; Anti-Infective Agents; Antimony; Antiprotozoal Agents; Cartilage; Ciprofloxacin; Ear, External; Humans; Immunocompetence; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pseudomonas Infections; Rifampin | 2006 |
Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH.
Topics: Animals; Antimony; Antiprotozoal Agents; Guanosine Monophosphate; Hydrogen-Ion Concentration; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Spectrometry, Mass, Electrospray Ionization; Thermodynamics | 2006 |
Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.
Topics: Adult; Antimony; Area Under Curve; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metabolic Clearance Rate; Organometallic Compounds; Plasma | 2007 |
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Geography; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Peru; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Species Specificity; Treatment Failure | 2007 |
Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Humans; Inhibitory Concentration 50; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Treatment Outcome | 2007 |
Enhanced oral delivery of antimony from meglumine antimoniate/beta-cyclodextrin nanoassemblies.
Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; beta-Cyclodextrins; Circular Dichroism; Delayed-Action Preparations; Drug Carriers; Female; Freeze Drying; Hot Temperature; Magnetic Resonance Spectroscopy; Meglumine; Meglumine Antimoniate; Mice; Models, Biological; Nanoparticles; Organometallic Compounds; Particle Size; Spectrometry, Mass, Electrospray Ionization | 2008 |
[Clinical and histological study of lupoid cutaneous leishmaniasis (16 cases)].
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Biopsy; Child; Disease Progression; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Skin; Time Factors; Treatment Outcome | 2007 |
[Demographic, clinical and therapeutic features of adult visceral leishmaniasis at the Rabta hospital in Tunis (tunisia) from 1983 to 2002].
Topics: Adult; Amphotericin B; Anemia; Animals; Antimony; Antiprotozoal Agents; Fever; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Splenomegaly; Treatment Outcome; Tunisia | 2007 |
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Dose-Response Relationship, Drug; Kidney Diseases; Kidney Function Tests; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2008 |
Mutilating lupoid leishmaniasis: twelve years to make the diagnosis!
Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Biopsy; Chronic Disease; Diagnosis, Differential; Follow-Up Studies; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Remission Induction; Skin; Time Factors | 2008 |
In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
Topics: Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; Chitosan; Female; Inhibitory Concentration 50; Leishmania infantum; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Microspheres; Organometallic Compounds; Parasitic Sensitivity Tests | 2008 |
Speciation of antimony (III) and antimony (V) using hydride generation for meglumine antimoniate pharmaceutical formulations quality control.
Topics: Antimony; Antiprotozoal Agents; Chemistry, Pharmaceutical; Flow Injection Analysis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quality Control; Spectrophotometry, Atomic | 2008 |
Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime.
Topics: Administration, Oral; Adult; Animals; Antimony; Antiprotozoal Agents; Atrial Premature Complexes; Bradycardia; Bundle-Branch Block; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Prospective Studies; Ventricular Premature Complexes | 2008 |
Speciation of Sb(III) and Sb(V) in meglumine antimoniate pharmaceutical formulations by PSA using carbon nanotube electrode.
Topics: Antimony; Chemistry, Pharmaceutical; Electrodes; Hydrogen-Ion Concentration; Meglumine; Meglumine Antimoniate; Nanotubes, Carbon; Organometallic Compounds; Osmolar Concentration; Potentiometry | 2009 |
Antimony containing drug and ECG abnormalities in children with visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Cardiovascular Abnormalities; Child; Child, Preschool; Electrocardiography; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2009 |
Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta).
Topics: Animals; Antimony; Antiprotozoal Agents; Kidney; Leishmania braziliensis; Leishmaniasis, Cutaneous; Liver; Macaca mulatta; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spleen | 2010 |
Genotoxic effects of the antileishmanial drug Glucantime.
Topics: Animals; Antimony; Apoptosis; Bone Marrow Cells; Cells, Cultured; Comet Assay; DNA; DNA Damage; Female; Humans; Lymphocytes; Macrophages, Peritoneal; Male; Meglumine; Meglumine Antimoniate; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens; Organometallic Compounds; Oxidation-Reduction; Trypanocidal Agents | 2010 |
Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate.
Topics: Adult; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Cutaneous; Male; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin; Treatment Outcome | 2009 |
Prolonged absorption of antimony(V) by the oral route from non-inclusion meglumine antimoniate-beta-cyclodextrin conjugates.
Topics: Absorption; Administration, Oral; Animals; Antimony; beta-Cyclodextrins; Circular Dichroism; Delayed-Action Preparations; Dogs; Female; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds | 2010 |
Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes.
Topics: Animals; Antimony; Antiprotozoal Agents; Brazil; Drug Resistance; Gene Expression Profiling; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasites; Treatment Outcome | 2010 |
Glucantime fever with parenteral meglumine antimonate in patients of cutaneous leishmaniasis.
Topics: Antimony; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2010 |
Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression.
Topics: Adult; Antimony; Antiprotozoal Agents; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Leishmaniasis, Cutaneous; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regeneration; Skin; Transforming Growth Factor beta; Treatment Failure | 2011 |
Disposition of antimony in rhesus monkeys infected with Leishmania braziliensis and treated with meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Erythrocytes; Female; Half-Life; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macaca mulatta; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxidation-Reduction; Reproducibility of Results; Spectrophotometry, Atomic; Thyroid Gland; Tissue Distribution | 2012 |
Serological monitoring of paediatric visceral leishmaniasis By IFA and ELISA methods.
Topics: Adolescent; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; DNA, Protozoan; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Turkey | 2011 |
Possible links between sickle cell crisis and pentavalent antimony.
Topics: Anemia, Sickle Cell; Antimony; Child; Glutathione; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2012 |
Speciation of antimony in injectable drugs used for leishmaniasis treatment (Glucantime®) by HPLC-ICP-MS and DPP.
Topics: Antimony; Antiprotozoal Agents; Chromatography, High Pressure Liquid; Humans; Leishmania; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pharmaceutical Preparations; Sensitivity and Specificity | 2012 |
Unexpectedly high levels of antimony (III) in the pentavalent antimonial drug Glucantime: insights from a new voltammetric approach.
Topics: Antimony; Electrochemical Techniques; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osmolar Concentration | 2013 |
Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Female; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Time Factors; Tissue Distribution | 2013 |
Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
Topics: Amplified Fragment Length Polymorphism Analysis; Antimony; Antiprotozoal Agents; Cell Line; DNA Fragmentation; DNA, Complementary; DNA, Protozoan; Drug Resistance; Genes, Protozoan; Inhibitory Concentration 50; Leishmania tropica; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Protozoan | 2013 |
Mixed antimony(V) complexes with different sugars to modulate the oral bioavailability of pentavalent antimonial drugs.
Topics: Administration, Oral; Animals; Antimony; Biological Availability; Carbohydrates; Circular Dichroism; Cyclodextrins; Humans; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds | 2014 |
Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia.
Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Cohort Studies; Colombia; Drug Resistance; Humans; Infant; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Randomized Controlled Trials as Topic; Young Adult | 2014 |
Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rats, Wistar; Time Factors; Tissue Distribution | 2014 |
Effects of in utero and lactational exposure to SbV on rat neurobehavioral development and fertility.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Estrus; Female; Fertility; Fetus; Lactation; Male; Meglumine; Meglumine Antimoniate; Milk; Motor Activity; Organometallic Compounds; Pregnancy; Rats; Rats, Wistar | 2014 |
Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
Topics: 3' Untranslated Regions; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Aquaglyceroporins; Aquaporin 1; Cell Movement; Drug Resistance; Gene Expression Regulation; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; RNA, Messenger; RNA, Protozoan | 2015 |
Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis.
Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Drug Carriers; Female; Hydrophobic and Hydrophilic Interactions; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Microscopy, Atomic Force; Nanoparticles; Organometallic Compounds; Scattering, Small Angle; Solvents; Treatment Outcome; X-Ray Diffraction | 2016 |
Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
Topics: Animals; Antimony; Antiprotozoal Agents; Aquaglyceroporins; Dog Diseases; Dogs; Drug Resistance; Gene Expression; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Sulfhydryl Compounds | 2016 |
Antimony resistance associated with persistence of Leishmania (Leishmania) infantum infection in macrophages.
Topics: Antimony; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis; Macrophages; Meglumine Antimoniate | 2021 |
Evaluating the Glucantime Concentration for the
Topics: Animals; Antimony; Antiprotozoal Agents; Humans; Leishmania tropica; Meglumine Antimoniate; Neuroglia; Rats; Rats, Sprague-Dawley | 2021 |
Assessing the effect of antimony pressure on trypanothione reductase activity in Leishmania (Viannia) braziliensis.
Topics: Antimony; Leishmania; Leishmania braziliensis; Meglumine Antimoniate | 2023 |
Distribution, metabolism, and toxicity of antimony species in wistar rats. A bio-analytical approach.
Topics: Animals; Antimony; Meglumine Antimoniate; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar | 2023 |